The American Cancer
Society estimates that approximately 266,120 women
will be diagnosed with breast
cancer in the United
States in 2018, and 40,920 will
die from the disease. This disease
represents the leading cause of
death among all female cancer
patients. Breast cancers encompass
a heterogeneous array of tumor
types that are classified according
to their histological and molecular
characteristics. To support your breast cancer research needs, ATCC provides breast cancer cell lines, a comprehensive Breast Cancer Resource Book, breast cancer tumor cell panels, and human primary and hTERT-immortalized mammary cells.
Tumors can arise from the ducts, lobules, or connective tissues of the breast. There are over 14 types of breast cancer. Thus, to generate the most known effective treatment options, investigators need in vitro research tools that represent the heterogeneity of breast cancers in vivo. ATCC has numerous breast cancer cell lines to support your research needs.
Browse the collection
Breast Cancer Resource Book
Breast Cancer Tumor Cell Panels
For optimal drug discovery studies, ATCC offers Tumor/Normal Matched Cell Line Pairs, Genetic Alteration Panels,
and Panels by Molecular Signature. ATCC Tumor Cell Panels
combine authenticated, well-characterized cell lines with
mutation data from the Sanger Institute Catalogue of
Somatic Mutations in Cancer (COSMIC) to create powerful
tools for cancer research and drug discovery.
CellMatrix Basement Membrane Gel
The extracellular matrix is important for the maintenance
of breast epithelium and is involved in oncogenic
transformation. CellMatrix Gel may be used to promote
spheroid formation in cancer cell lines in vitro, making it
useful for the screening of anti-cancer drugs.